Drugs / TRx0037
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01253499 | Mar → May 2010 | Alzheimer disease | TauRx Therapeutics Ltd | Completed | No outcome recorded |
| Phase 1 | NCT01253122 | Feb → Apr 2010 | Alzheimer disease | TauRx Therapeutics Ltd | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TRx0037 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01253499 ↗ |